ATORX — Alligator Bioscience AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK670.76m
- SEK620.74m
- SEK58.11m
Annual cashflow statement for Alligator Bioscience AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -215 | -144 | -142 | -193 | -249 |
| Depreciation | |||||
| Non-Cash Items | 0.301 | 0.042 | 0.069 | 0.08 | 0.073 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 21.6 | -8.62 | 3.32 | 8.34 | 49.1 |
| Change in Accounts Receivable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -181 | -141 | -127 | -173 | -189 |
| Capital Expenditures | -2.19 | -0.102 | -0.045 | -0.44 | -2.46 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 170 | 157 | 0 | — | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 168 | 157 | -0.045 | -0.44 | -2.46 |
| Financing Cash Flow Items | 0.001 | — | -33.9 | -0.343 | -24.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.3 | -6.15 | 302 | -7.83 | 162 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -18.1 | 9.53 | 175 | -181 | -31.2 |